A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples